Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen

Klinik und Poliklinik für Geburtshilfe und Frauengesundheit

Klinikum / Johannes Gutenberg-Universität Mainz

Publikationen
Ergebnisse pro Seite:  10

Battista, Marco Johannes; Cotarelo, Cristina; Jakobi, Sina et al.

Overexpression of epithelial cell adhesion molecule protein is associated with favorable prognosis in an unselected cohort of ovarian cancer patients

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. Bd. 140. H. 7. 2014 S. 1097-1102


Kreipe, H; Schmidt, M

Pathologie, Prognose und Prädiktion

Untch, Harbeck, Thomssen, Costa (Hrsg). Colloquium Senologie 2014/2015. München: Agileum Verlag GmbH 2014


Schmidt, M.; Untch, M.

Prediction of benefit from chemotherapy in ER-positive/HER2-negative breast cancer-a problem still to be solved

ANNALS OF ONCOLOGY. Bd. 25. H. 3. 2014 S. 754-754


Sicking, Isabel; Rommens, Karlien; Battista, Marco J. et al.

Prognostic influence of cyclooxygenase-2 protein and mRNA expression in node-negative breast cancer patients

BMC CANCER. Bd. 14. 2014


Sicking, Isabel; Edlund, Karolina; Wesbuer, Eva et al.

Prognostic Influence of Pre-Operative C-Reactive Protein in Node-Negative Breast Cancer Patients

PLOS ONE. Bd. 9. H. 10. 2014


Milde-Langosch, Karin; Karn, Thomas; Schmidt, Marcus et al.

Prognostic relevance of glycosylation-associated genes in breast cancer

BREAST CANCER RESEARCH AND TREATMENT. Bd. 145. H. 2. 2014 S. 295-305


Heitz, Florian; Amant, Frederic; Fotopoulou, Christina et al.

Synchronous Ovarian and Endometrial Cancer-an International Multicenter Case-Control Study

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. Bd. 24. H. 1. 2014 S. 54-60


Gomez, Ruth; Schorsch, Martin; Steetskamp, Joscha et al.

The effect of ovarian stimulation on the outcome of intrauterine insemination

ARCHIVES OF GYNECOLOGY AND OBSTETRICS. Bd. 289. H. 1. 2014 S. 181-185


Witzel, Isabell; Graeser, Monika; Karn, Thomas et al.

Androgen receptor expression is a predictive marker in chemotherapy-treated patients with endocrine receptor-positive primary breast cancers

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. Bd. 139. H. 5. 2013 S. 809-816


Rodriguez-Lescure, A.; Brase, J. C.; Schmidt, M. et al.

Biomarkers for predicting taxane efficacy in ER+/HER2-breast cancer patients: From in-vitro chemosensitivity screening to clinical validation in the GEICAM/ 9906 trial

EUROPEAN JOURNAL OF CANCER. Bd. 49. 2013 S. S475-S475